Study details
Enrolling now
Dynamic Treatment Regiments for Glucocorticoid Tapering
VA Office of Research and Development
NCT IDNCT06072768ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
200
Study length
about 7 years
Ages
18+
Locations
2 sites in MI
About this study
This trial is testing different ways to gradually reduce steroid medications (like prednisone) in people with rheumatoid arthritis. The goal is to understand why some people experience problems when the dose is lowered, while others don't. Researchers will look at various factors like inflammation levels and hormone balances to better understand these differences.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take 15-day taper prednisone
- 2.Take 150-day taper prednisone
PhasePhase 2
Drug15-day taper prednisone
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
corticosteroid (Glucocorticoid; suppresses inflammation and immune response)
Drug routes
oral
Body systems
Immune